Based on this YouTube video's total view count of 574K views and industry-standard rates, the estimated total earning is $402 - $1.15K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Activated Vitamin D trial with 574,261 views, 30,385 likes, and 3,573 comments. Experience the impact of this video content that has captured audience attention.

Free download John’s textbooks in high res pdf. https://drjohncampbell.co.uk Order my Physiology Notes in hard copy if you live in the UK, https://www.ebay.co.uk/itm/154973392319?mkcid=16&mkevt=1&mkrid=711-127632-2357-0&ssspo=K6raxMZrQnm&sssrc=2047675&ssuid=&widget_ver=artemis&media=EMAIL The effect of 1-hydroxy-vitamin D treatment in hospitalized patients with COVID-19: A retrospective study https://www.sciencedirect.com/science/article/pii/S0261561423002790 Vitamin D deficiency is associated with elevated risk, severity, and mortality Asthma, tuberculosis, chronic pulmonary obstructive disease (COPD), and viral respiratory infections Consistent paper 1. Vitamin D and its therapeutic relevance in pulmonary diseases https://www.sciencedirect.com/science/article/abs/pii/S0955286320306033?via%3Dihub Vitamin D essential for several cellular processes, wound healing, immunity inflammation Studies have displayed strong inter-relations with vit D deficiency and progression of lung disorders Its ease of supplementation and development of personalized medicine, could lead us to an effective adjunct and cost-effective method of therapeutic modality for highly fatal pulmonary diseases. Consistent paper 2. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths https://www.mdpi.com/2072-6643/12/4/988 To reduce the risk of infection, it is recommended that people at risk of influenza and/or COVID-19, consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly raise 25(OH)D concentrations, followed by 5000 IU/d. The goal should be to raise 25(OH)D concentrations above 40–60 ng/mL (100–150 nmol/L). For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful. Vitamin D deficiency is relatively common Especially among the elderly, the obese, and patients with comorbidities including hypertension, diabetes, COPD, and CKD Vitamin D induces Production of antiviral peptides (defensins), especially in the respiratory epithelium Vitamin D upregulates anti-inflammatory cytokines such as interleukin-10 (IL-10), and downregulates pro-inflammatory cytokines including IL-1, IL-6, and tumor necrosis factor alfa Vitamin D effects angiotensin-converting enzyme axis, which has a protective effect against ARDS Efficacy of activated vitamin D supplementation in coronavirus disease 2019 (COVID-19) 1-hydroxy-vitamin D was prescribed on day 1 or 2 (median duration 8 days) To evaluate the effect of 1-hydroxy-vitamin D, on the prevention of severe disease and mortality, in patients hospitalized for COVID-19. Retrospective study, April 2021 and October 2021 Primarily Delta variant Hospitalised 312 patients with COVID-19 Between July 2022 and September 2022 Primarily Omicron variant Serum 25-hydroxyvitamin D (25(OH)D) levels measured at admission 1-hydroxy-vitamin D was prescribed Primary composite endpoints Need for additional respiratory support Need for high-flow oxygen therapy or invasive mechanical ventilation In-hospital mortality rate. Experimental group (n = 122) Given 1-hydroxy-vitamin D Median age, 66 Baseline vitamin D deficient, 77% Control group ( n = 190) Median age, 58 Age difference (p = 0.06) Baseline vitamin D deficient, 65% Baseline D deficiency (p = 0.07) (defined as serum 25(OH)D level less than 20 ng/mL) Proportion of those requiring more respiratory support and in-hospital mortality Vit D group, 6% Control group,14% (p = 0.01) After propensity score matching (to reduce bias caused by confounding variables) (P = 0.03 log-rank test) Proportion of patients who received high flow oxygen Vit D group 4% Control group, 11% (P = 0.04) In-hospital mortality Vit D group, 3% Control group, 5% (P = 0.3). Need for additional respiratory support Vit D group, 6% Control group, 14% (P = 0.01) Conclusions 1-hydroxy-vitamin treatment may improve outcomes in hospitalized patients with COVID- 19, reducing composite outcomes including the need for additional respiratory support and in-hospital mortality.

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.